{
  "nct_id": "NCT04732065",
  "official_title": "Open Label Phase 1 and Target Validation Study of ONC206 in Children and Young Adults With Newly Diagnosed or Recurrent Diffuse Midline Glioma (DMG), and Other Recurrent Primary Malignant Central Nervous System (CNS) Tumors",
  "brief_title": "ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors",
  "cancer_type_display": "A study for children and young adults with newly diagnosed or recurrent diffuse midline gliomas (DMG) and other recurrent malignant central nervous system (CNS) tumors like glioblastoma and ependymoma.",
  "cancer_tags": [
    "Diffuse Midline Glioma (DMG)",
    "Glioblastoma",
    "Recurrent Ependymoma",
    "Recurrent Malignant Central Nervous System Neoplasm",
    "Spinal Cord Glioma",
    "World Health Organization (WHO) Grade III Glioma",
    "CNS Tumor",
    "Central Nervous System Tumor"
  ],
  "link_to_trial": "https://clinicaltrials.gov/study/NCT04732065",
  "phase": "Phase 1",
  "recruitment_status": "RECRUITING",
  "last_update_date": "2025-07-14",
  "enrollment": 208,
  "min_age": 2,
  "max_age": 21,
  "sex": "ALL",
  "is_metastatic_allowed": null,
  "performance_status_scale": null,
  "performance_status_values": null,
  "min_prior_lines": 0,
  "max_prior_lines": null,
  "prior_treatments_required": [
    "Focal radiation therapy (for specific arms)"
  ],
  "prior_treatments_excluded": [
    "Current treatment with other investigational drugs",
    "Current treatment with other anti-cancer agents",
    "Strong inhibitors or inducers of CYP3A4, 2D6, 1A2, 2C9 and 2C19",
    "Prior ONC201 in the upfront setting (for specific arms)"
  ],
  "principal_investigator": "Sabine Mueller, MD, PhD",
  "site_name": "University of California, San Francisco",
  "contact_email": "PNOC023@ucsf.edu",
  "contact_phone": "(415) 502-1600",
  "locations": [
    {
      "facility": "University of California, San Francisco",
      "status": "RECRUITING",
      "city": "San Francisco",
      "state": "California",
      "zip": "94143",
      "country": "United States",
      "contacts": [
        {
          "name": "PNOC Operations",
          "role": "CONTACT",
          "phone": "415-502-1600",
          "email": "PNOC023@ucsf.edu"
        },
        {
          "role": "CONTACT",
          "email": "PNOC023@ucsf.edu"
        },
        {
          "name": "Sabine Mueller, MD, PhD",
          "role": "PRINCIPAL_INVESTIGATOR"
        }
      ],
      "geoPoint": {
        "lat": 37.77493,
        "lon": -122.41942
      }
    },
    {
      "facility": "Emory University",
      "status": "RECRUITING",
      "city": "Atlanta",
      "state": "Georgia",
      "zip": "30322",
      "country": "United States",
      "contacts": [
        {
          "name": "Tobey MacDonald, MD",
          "role": "CONTACT",
          "email": "tobey.macdonald@emory.edu"
        }
      ],
      "geoPoint": {
        "lat": 33.749,
        "lon": -84.38798
      }
    },
    {
      "facility": "University of Michigan",
      "status": "RECRUITING",
      "city": "Ann Arbor",
      "state": "Michigan",
      "zip": "48109",
      "country": "United States",
      "contacts": [
        {
          "name": "Carl Koschmann, MD",
          "role": "CONTACT",
          "email": "CCPBTC-CRA@med.umich.edu"
        },
        {
          "name": "Andrea Franson, MD",
          "role": "CONTACT"
        }
      ],
      "geoPoint": {
        "lat": 42.27756,
        "lon": -83.74088
      }
    },
    {
      "facility": "Children's Hospital of Philadelphia",
      "status": "RECRUITING",
      "city": "Philadelphia",
      "state": "Pennsylvania",
      "zip": "19104",
      "country": "United States",
      "contacts": [
        {
          "name": "Cassie Kline, MD",
          "role": "CONTACT",
          "phone": "215-590-2299",
          "email": "klinec@chop.edu"
        },
        {
          "name": "Cassie Kline, MD",
          "role": "PRINCIPAL_INVESTIGATOR"
        }
      ],
      "geoPoint": {
        "lat": 39.95238,
        "lon": -75.16362
      }
    },
    {
      "facility": "The University Children's Hospital in Zurich",
      "status": "RECRUITING",
      "city": "Zurich",
      "state": "Canton of Zurich",
      "zip": "8032",
      "country": "Switzerland",
      "contacts": [
        {
          "name": "Nicolas Gerber, MD",
          "role": "CONTACT",
          "phone": "+41 44 266 3117",
          "email": "glioma@kispi.uzh.ch"
        },
        {
          "name": "Stephanie Matthes, PhD",
          "role": "CONTACT",
          "phone": "+41 44 266 3726",
          "email": "glioma@kispi.uzh.ch"
        }
      ],
      "geoPoint": {
        "lat": 47.36667,
        "lon": 8.55
      }
    }
  ],
  "key_inclusion_summary": [
    "Diagnosis of newly diagnosed or recurrent H3K27-altered diffuse midline glioma (DMG), or other recurrent primary malignant CNS tumors.",
    "Age between 2 and 21 years for dose escalation cohorts.",
    "Karnofsky performance status >= 50 (for age > 16) or Lansky >= 50 (for age <= 16).",
    "Adequate bone marrow and organ function.",
    "Willingness to provide adequate tumor tissue sample."
  ],
  "key_exclusion_summary": [
    "Currently receiving other investigational drugs or anti-cancer agents.",
    "Known immunodeficiency disorders like HIV or Hepatitis B/C, or autoimmune disorders requiring systemic immunosuppressive therapy.",
    "Uncontrolled infection.",
    "Female participants who are pregnant or breastfeeding.",
    "Use of strong inhibitors or inducers of CYP3A4, 2D6, 1A2, 2C9 and 2C19 enzymes within 14 days of starting the study drug."
  ]
}